The purpose of this supplemental FOA is to fund a select set of project areas with high rates of congenital syphilis to go above and beyond the activities supported by STD AAPPS and bolster congenital syphilis control and prevention.
The CDC, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of STD Prevention (DSTDP) has developed this 15 month supplemental Funding Opportunity Announcement (FOA) titled, “STD AAPPS Supplemental Funding for Enhanced Congenital Syphilis Response,” to strengthen capacity to address congenital syphilis in the United States and build upon activities supported under FOA CDC RFA-PS14-1402, “Improving Sexually Transmitted Disease Programs through Assessment, Assurance, Policy Development, and Prevention Strategies” (STD AAPPS). Under CDC-RFA-PS14-1402 there are 59 State, local, and territorial project areas currently funded to conduct assessment, assurance, and policy strategies related to STD prevention and control. STD AAPPS began January 1, 2014, for a 5-year project period. The purpose of this supplemental FOA is to fund a select set of project areas with high rates of congenital syphilis to go above and beyond the activities supported by STD AAPPS and bolster congenital syphilis control and prevention. The primary goal of this supplemental FOA is to strengthen the local response to congenital syphilis in the United States. The activities outlined in this FOA are expected to strengthen local and national capacity to address congenital syphilis. This supplemental FOA will support approximately 9 awardees currently funded under CDC-RFA-PS14-1402, STD AAPPS. Measurable outcomes of the program will be in alignment with one (or more) of the following performance goal(s) for the NCHHSTP:
This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be reviewed. For the definition of research, please click here.
For complete funding announcement, please click on the resource link above.